Medicare would require facilities offering nerve and muscle tests to meet new quality standards to protect patients.
Medicare would stop paying for certain nerve and muscle tests, like nerve conduction studies, unless the facility providing them meets new quality standards. This bill aims to protect patients and prevent fraud. It does this by requiring facilities to be accredited and ensure proper equipment, trained staff, and on-site interpretation of results.
Currently, Medicare pays for nerve conduction studies and needle electromyography tests. There are no specific federal requirements for facility accreditation or detailed quality standards for these services. If this bill becomes law, Medicare would stop paying for these services 3 to 4 years after enactment. This would apply unless the services are provided by facilities accredited by approved organizations. These organizations would enforce new standards for quality, equipment, staff training, and on-site interpretation.
HR 3092 · 119th Congress · April 30, 2025 · AI Summary by gemini-2.5-flash · 9/10
Sign in to see your representatives' phone numbers